Status:
COMPLETED
Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the prevalence of brainstem dysfunction in critically ill ventilated and deeply sedated patients hospitalized in the Intensive Care Unit (ICU) for a SARS-CoV-...
Detailed Description
The recent development of the pandemic due to the SARS-CoV-2 virus has showed that a substantial proportion of patients developed a severe condition requiring critical care, notably because of acute r...
Eligibility Criteria
Inclusion
- ICU hospitalization
- Invasive mechanical ventilation
- Deep sedation (RASS\<-3) \>12 hours
- Positive SARS-COV-2 PCR
Exclusion
- History of neurologic disease (stroke, degenerative disease)
- Pregnant women
- Moribund patients
- Minor patient
- Major patient under guardianship or curatorship
- Prior inclusion in the study
- Patient not affiliated to a social security scheme
- Limitations and cessation of active therapies
Key Trial Info
Start Date :
September 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04527198
Start Date
September 14 2020
End Date
December 31 2020
Last Update
December 9 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Cochin
Paris, France, 75014
2
HEGP
Paris, France, 75015